Stock MGTX MEIRAGTX HOLDINGS PLC
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MeiraGTx Holdings plc

Equities

MGTX

KYG596651029

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-21 EDT 		5-day change 1st Jan Change
4.4 USD +2.09% Intraday chart for MeiraGTx Holdings plc -2.00% -37.32%
06-12 Transcript : MeiraGTx Holdings plc Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 02:40 PM
05-15 Transcript : MeiraGTx Holdings plc Presents at Bank of America Health Care Conference 2024, May-15-2024 10:40 AM

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MeiraGTx Reports First Quarter 2024 Financial and Operational Results
GL
MeiraGTx : Results of a Phase 1, Open-label, Dose-escalation Study of Gene Therapy with AAV2-hAQP1 as Treatment for Grade 2 and 3 Radiation-induced Late Xerostomia and Parotid Gland Hypofunction – The AQUAx Study
PU
MeiraGTx to Participate in Upcoming Investor Conferences
GL
MeiraGTx Announces Oral Presentation at the 2024 American Academy of Oral Medicine (AAOM) Annual Conference
GL
MeiraGTx Reports Fourth Quarter and Full Year 2023 Financial and Operational Results and Recent Business Updates
GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
GL
MeiraGTx Announces $50 Million Milestone from Janssen Pharmaceuticals
AQ
Progress In Preventing Blindness
AQ
Enavate Sciences Backs Graviton Bioscience in Financing Round to Advance Development of Selective ROCK2 Inhibitors
AQ
MeiraGTx sells XLRP gene therapy to Janssen
AQ
MeiraGTx Announces Asset Purchase Agreement Involving its AAV-RPGR Collaboration for up to $415 million
GL
MeiraGTx to Participate in Upcoming Investor Conferences
GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
GL
MeiraGTx Announces Third Quarter 2023 Financial and Operational Results
AQ
BestGrowthStocks.Com: MeiraGTx Holdings plc Actively Pursuing Strategic Partnerships and Asset Interest, Potential Transactions
AQ
MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities
GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
GL
MeiraGTx Announces an Oral Presentation and Eight Posters at the European Society of Gene and Cell Therapy (ESGCT) 2023 Annual Congress
AQ
Janssen to Highlight Latest Advances in Retina Portfolio at the European Society of Retina Specialists 2023 Annual Meeting
AQ
MeiraGTx Reports Second Quarter 2023 Financial and Operational Results
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MGTX Stock
  4. News MeiraGTx Holdings plc
  5. Press Releases